How many insider declarations has Liu Ye filed?

Liu Ye has filed 4 public insider declarations with SEC (Form 4).

What is Liu Ye's role?

Liu Ye's reported role is not specified by the regulator across the filings.

Which companies does Liu Ye report trades for?

Liu Ye reports trades for 2 companies, including EyePoint Pharmaceuticals, Inc..

What is Liu Ye's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 47.3M€.

← Executives ★ Sign in to follow

LY

Liu Ye

·SEC (Form 4)

EyePoint Pharmaceuticals, Inc.Ocumension Therapeutics - B

Cumul. flow

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€47m

▼ Sales (3 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

3

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by Liu Ye. Director active across 2 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 4 disclosures have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €47.3m. Activity tracked since 30 May 2023. The latest transaction was filed on 11 January 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Liu Ye

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

EyePoint Pharmaceuticals, Inc. (US)Ocumension Therapeutics - B (HK)

Declarations4 total

●

Liu Ye

DirectorExecutives26 Jun 2026Ocumension Therapeutics - B

0HKEX ↗

203,459 sharesShareXHKGHKEX:DA20260702E00732

▼

Liu Ye

DirectorExecutives11 Jan 2024EyePoint Pharmaceuticals, Inc.

$37M33SEC ↗

1,910,500 shares@ US$19.4571.5% of flowCommon Stock, $0.001 par valueSEC:0001562180-24-000466:0

▼

Liu Ye

DirectorExecutives5 Dec 2023EyePoint Pharmaceuticals, Inc.

$15M29SEC ↗

733,758 shares@ US$19.9128.5% of flowCommon Stock, $0.001 par valueSEC:0001562180-23-008222:0

▼

Liu Ye

DirectorExecutives30 May 2023EyePoint Pharmaceuticals, Inc.

$611SEC ↗

1 shares@ US$6.000.0% of flowCommon Stock, $0.001 par valueSEC:0001562180-23-004632:0

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

LY

Liu Ye

·SEC (Form 4)

EyePoint Pharmaceuticals, Inc.Ocumension Therapeutics - B

Cumul. flow

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€47m

▼ Sales (3 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

3

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by Liu Ye. Director active across 2 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 4 disclosures have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €47.3m. Activity tracked since 30 May 2023. The latest transaction was filed on 11 January 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.